AR059353A1 - DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. - Google Patents

DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES.

Info

Publication number
AR059353A1
AR059353A1 ARP070100507A AR059353A1 AR 059353 A1 AR059353 A1 AR 059353A1 AR P070100507 A ARP070100507 A AR P070100507A AR 059353 A1 AR059353 A1 AR 059353A1
Authority
AR
Argentina
Prior art keywords
alkyl
aryl
group
nr9r10
heteroaryl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Harry Finch
Nicholas Charles Ray
Richard James Bull
Den Heuvel Marco Van
Jose Antonio Bravo
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to ARP070100507 priority Critical patent/AR059353A1/en
Publication of AR059353A1 publication Critical patent/AR059353A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos en el tratamiento de enfermedades donde está implicada una activacion de los receptores M3, tales como las enfermedades del tracto respiratorio. Reivindicacion 1: Un compuesto de formula (1); en la cual (i) R1 es alquilo C1-6 o hidrogeno; y R2 es hidrogeno o un grupo R7, -Z-Y-R7, -Z-NR9R10; -Z-CO-NR9R10, -Z-NR9-C(O)O-R7, o -Z-C(O)-R7; y R3 es un par solitario o alquilo C1-6, o (ii) R1 y R3 junto con el nitrogeno al cual están unidos forman un anillo de heterocicloalquilo, y R2 es un par solitario o un grupo -R7, -Z-Y-R7, -Z-NR9R10, -Z-CO-NR9R10, -Z-NR9-C(O)O-R7 o -Z-C(O)-R7; o (iii) R1 y R2 junto con el nitrogeno al cual están unidos forman un anillo de heterocicloalquilo, y dicho anillo está substituido por un grupo -Y-R7, -Z-Y-R7, Z-NR9R10, -Z-CO-NR9R10; -Z-NR9-C(O)O-R7 o -Z-C(O)-R7; y R3 es un par solitario o alquilo C1-6; y R4 y R5 se seleccionan independientemente entre el grupo que comprende arilo, heterocicloalquilo fusionado o arilo, heteroarilo, alquilo C1-6, cicloalquilo; R6 es -OH, halogeno, alquilo C1-6, alcoxi C1-6, hidroxi-alquilo C1-6, nitrilo, un grupo CONR82 o un H; A es O o S; X es alquinileno, alquenileno o alquinileno; R7 es un grupo alquilo C1-6, arilo, cicloalquilo fusionado a arilo, heterocicloalquilo fusionado a arilo, heteroarilo, aril (alquiloC1-8)-, heteroaril (alquiloC1-8)-, cicloalquilo o heterocicloalquilo; R8 es alquilo C1-6 o un átomo de hidrogeno; Z es un grupo alquileno C1-16, alquenileno C2-16 o alquinileno C2-16; Y es un enlace o átomo de hidrogeno; R9 y R10 son independientemente un átomo de H, alquilo C1-6, arilo, heterocicloalquilo fusionado a arilo, cicloalquilo fusionado a arilo, heteroarilo, aril (alquilo C1-6) o heteroaril (alquilo C1-6)-; o R9 y R10 junto con el átomo de nitrogeno al cual están unidos forman un anillo heterocíclico de 4-8 átomos, que opcionalmente contiene otro átomo de nitrogeno u oxígeno; o su sal farmacéuticamente aceptable, solvato, N-oxido o profármaco.Compounds in the treatment of diseases where an activation of M3 receptors is involved, such as respiratory tract diseases. Claim 1: A compound of formula (1); in which (i) R 1 is C 1-6 alkyl or hydrogen; and R2 is hydrogen or a group R7, -Z-Y-R7, -Z-NR9R10; -Z-CO-NR9R10, -Z-NR9-C (O) O-R7, or -Z-C (O) -R7; and R3 is a solitary pair or C1-6 alkyl, or (ii) R1 and R3 together with the nitrogen to which they are attached form a heterocycloalkyl ring, and R2 is a solitary pair or a group -R7, -ZY-R7, -Z-NR9R10, -Z-CO-NR9R10, -Z-NR9-C (O) O-R7 or -ZC (O) -R7; or (iii) R1 and R2 together with the nitrogen to which they are attached form a heterocycloalkyl ring, and said ring is substituted by a group -Y-R7, -Z-Y-R7, Z-NR9R10, -Z-CO-NR9R10; -Z-NR9-C (O) O-R7 or -Z-C (O) -R7; and R3 is a solitary pair or C1-6 alkyl; and R4 and R5 are independently selected from the group comprising aryl, fused heterocycloalkyl or aryl, heteroaryl, C1-6 alkyl, cycloalkyl; R6 is -OH, halogen, C1-6 alkyl, C1-6 alkoxy, hydroxy-C1-6 alkyl, nitrile, a CONR82 group or an H; A is O or S; X is alkynylene, alkenylene or alkynylene; R7 is a C1-6 alkyl, aryl, aryl fused cycloalkyl, aryl fused heterocycloalkyl, heteroaryl, aryl (C1-8 alkyl) -, heteroaryl (C1-8 alkyl) -, cycloalkyl or heterocycloalkyl group; R8 is C1-6 alkyl or a hydrogen atom; Z is a C1-16 alkylene, C2-16 alkenylene or C2-16 alkynylene group; And it is a hydrogen bond or atom; R9 and R10 are independently an atom of H, C1-6 alkyl, aryl, aryl fused heterocycloalkyl, aryl fused cycloalkyl, heteroaryl, aryl (C1-6 alkyl) or heteroaryl (C1-6 alkyl) -; or R9 and R10 together with the nitrogen atom to which they are attached form a heterocyclic ring of 4-8 atoms, which optionally contains another nitrogen or oxygen atom; or its pharmaceutically acceptable salt, solvate, N-oxide or prodrug.

ARP070100507 2007-02-07 2007-02-07 DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES. AR059353A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP070100507 AR059353A1 (en) 2007-02-07 2007-02-07 DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070100507 AR059353A1 (en) 2007-02-07 2007-02-07 DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES.

Publications (1)

Publication Number Publication Date
AR059353A1 true AR059353A1 (en) 2008-03-26

Family

ID=39272771

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100507 AR059353A1 (en) 2007-02-07 2007-02-07 DERIVATIVES OF OXAZOL AND TIAZOL. PHARMACEUTICAL COMPOSITIONS AND USES.

Country Status (1)

Country Link
AR (1) AR059353A1 (en)

Similar Documents

Publication Publication Date Title
AR046297A1 (en) DPP INHIBITORS - IV METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE AGENTS
AR047098A1 (en) ARILANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEIVER AGONISTS
AR083849A1 (en) ESPIRO-OXINDOL MDM2 ANTAGONISTS
AR044874A1 (en) DERIVATIVES OF 4- CIANOPIRAZOL-3 - CARBOXAMIDE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR083070A1 (en) ANALOGS OF NUCLEOTID REPLACED WITH NITROGEN HETEROCICLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME TO TREAT VIRAL DISEASES, IN PARTICULAR HCV INFECTIONS
JP2008526999A5 (en)
CL2009000127A1 (en) [Indole, azaindole] -2-carboxamide derivative compounds substituted with a silanyl group; preparation procedure; intermediate compounds; pharmaceutical composition; and its use in the treatment of pain, inflammation, metabolic disorders, among other diseases mediated by modulation of the trpv1 receptor.
AR049464A1 (en) ANTAGONISTS OF MUSCARINIC ACETILCOLINE RECEPTORS. PHARMACEUTICAL COMPOSITIONS
AR058073A1 (en) IMIDAZOL 5-IL-PYRIMIDINE DERIVATIVES, OBTAINING PROCESSES, PHARMACEUTICAL COMPOSITIONS AND USES
CO5700720A2 (en) DERIVATIVES OF N- (QUINOLIN-5L) ALQUILAMIDA-REPLACED; N-ALQUILQUINOLIN-5-CARBOXAMIDA-REPLACED; N-ALQUILISOQUINOLIN-5-CARBOXAMIDA-SUBSTITUTED; N- (ISOQUINOLIN-5-YL) ALQUILAMIDA-REPLACED AND PROCESSES FOR PREPARATION
AR035617A1 (en) COMPOUNDS DERIVED FROM PHENETHANOLAMINE, COMBINATIONS AND PHARMACEUTICAL FORMULATIONS OF THE SAME, PROCESS FOR THEIR PREPARATION, ITS USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OR PROPHYLAXIS OF A CLINICAL CONDITION FOR WHICH A BETAIEPAR BARDIAR AGENT IS ADDED
PE20151602A1 (en) SALTS OF DERIVATIVES OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2 (1H) -ONE THAT HAVE AGONISTIC ACTIVITY OF THE B (beta) 2 ADRENERGIC RECEPTOR AS WELL AS ANTAGONIST ACTIVITY OF THE MUSCARINIC RECEPTOR M3
AR083069A1 (en) ANALOGS OF SUBSTITUTED NUCLEOTIDES
AR082994A1 (en) PYRAZINE DERIVATIVES AS BLOCKERS OF THE SODIUM EPITELIAL CHANNEL
AR064253A1 (en) BICYCLOCARBOXYAMIDE COMPOUNDS REPLACED PHARMACEUTICAL COMPOSITIONS AND A COMBINATION THAT INCLUDES THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE RECEIVER'S ACTIVITY VR1
HRP20080052T3 (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
AR052938A1 (en) N-SULFONYLAMINOFENILETIL-2-PHENOXYACETAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY RECEIVER VR1
AR069490A1 (en) GLUCOCORTICOID RECEPTORS AGONISTS
AR054272A1 (en) DERIVATIVES OF 3- AMINOPIRRILIDINAS TRI, TETRA - SUBSTITUTED
AR087915A1 (en) N- (3- (2-AMINO-6,6-DIFLUOR-4,4A, 5,6,7,7A-HEXAHYDRO-CYCLOPENTA- [E] [1,3] OXAZIN-4-IL) -PENYL) - AMIDAS AS INHIBITORS OF THE BACE1
AR059328A1 (en) DERIVATIVES OF ANTRANILAMIDA-2-AMINO-HETEROARENO-CARBOXAMIDA, A PROCESS FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF THESE COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CETP MEDIATION
PE20081227A1 (en) INDAZOLYL SULPHONAMID DERIVATIVES AS MODULATORS OF GLUCOCORTICOIDES
AR060604A1 (en) NEW ARILAMINO N- HETEROARILOS AS MEK INHIBITORS
AR067412A1 (en) PHARMACEUTICAL PROPERTY MODULATORS OF THERAPEUTIC PRODUCTS
AR063275A1 (en) CARBOXAMIDE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE ACTIVATION OF CCR2.

Legal Events

Date Code Title Description
FB Suspension of granting procedure